217 related articles for article (PubMed ID: 32169913)
21. Clinical Translation and First In-Human Use of [
Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
[TBL] [Abstract][Full Text] [Related]
22. Biodistribution and radiation dosimetry of [
Hohberg M; Kobe C; Krapf P; Täger P; Hammes J; Dietlein F; Zlatopolskiy BD; Endepols H; Wild M; Neubauer S; Heidenreich A; Neumaier B; Drzezga A; Dietlein M
EJNMMI Res; 2019 Jul; 9(1):66. PubMed ID: 31346821
[TBL] [Abstract][Full Text] [Related]
23.
Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
[TBL] [Abstract][Full Text] [Related]
24.
O'Doherty J; Jauregui-Osoro M; Brothwood T; Szyszko T; Marsden PK; O'Doherty MJ; Cook GJR; Blower PJ; Lewington V
J Nucl Med; 2017 Oct; 58(10):1666-1671. PubMed ID: 28385795
[TBL] [Abstract][Full Text] [Related]
25. Radiation Dosimetry and Biodistribution of
Meyer C; Dahlbom M; Lindner T; Vauclin S; Mona C; Slavik R; Czernin J; Haberkorn U; Calais J
J Nucl Med; 2020 Aug; 61(8):1171-1177. PubMed ID: 31836685
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of
Bullich S; Barret O; Constantinescu C; Sandiego C; Mueller A; Berndt M; Papin C; Perrotin A; Koglin N; Kroth H; Pfeifer A; Tamagnan G; Madonia J; Seibyl JP; Marek K; De Santi S; Dinkelborg LM; Stephens AW
J Nucl Med; 2020 Jun; 61(6):920-927. PubMed ID: 31712324
[No Abstract] [Full Text] [Related]
27. Preclinical Incorporation Dosimetry of [
Sattler B; Kranz M; Wenzel B; Jain NT; Moldovan RP; Toussaint M; Deuther-Conrad W; Ludwig FA; Teodoro R; Sattler T; Sadeghzadeh M; Sabri O; Brust P
Molecules; 2020 Apr; 25(9):. PubMed ID: 32357571
[TBL] [Abstract][Full Text] [Related]
28. High in-vivo stability in preclinical and first-in-human experiments with [
Qin X; Guo X; Liu T; Li L; Zhou N; Ma X; Meng X; Liu J; Zhu H; Jia B; Yang Z
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):302-313. PubMed ID: 36129493
[TBL] [Abstract][Full Text] [Related]
29. Biodistribution and radiation dosimetry of (68)Ga-PSMA HBED CC-a PSMA specific probe for PET imaging of prostate cancer.
Pfob CH; Ziegler S; Graner FP; Köhner M; Schachoff S; Blechert B; Wester HJ; Scheidhauer K; Schwaiger M; Maurer T; Eiber M
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1962-70. PubMed ID: 27207281
[TBL] [Abstract][Full Text] [Related]
30. Clinical translation of
Dubash SR; Keat N; Kozlowski K; Barnes C; Allott L; Brickute D; Hill S; Huiban M; Barwick TD; Kenny L; Aboagye EO
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2549-2561. PubMed ID: 32123971
[TBL] [Abstract][Full Text] [Related]
31. Biodistribution, Radiation Dosimetry, and Clinical Application of a Melanin-Targeted PET Probe,
Ma X; Wang S; Wang S; Liu D; Zhao X; Chen H; Kang F; Yang W; Wang J; Cheng Z
J Nucl Med; 2019 Jan; 60(1):16-22. PubMed ID: 29853651
[No Abstract] [Full Text] [Related]
32. Human biodistribution and radiation dosimetry of the tachykinin NK1 antagonist radioligand [18F]SPA-RQ: comparison of thin-slice, bisected, and 2-dimensional planar image analysis.
Sprague DR; Chin FT; Liow JS; Fujita M; Burns HD; Hargreaves R; Stubbs JB; Pike VW; Innis RB; Mozley PD
J Nucl Med; 2007 Jan; 48(1):100-7. PubMed ID: 17204705
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice.
Constantinescu CC; Sevrioukov E; Garcia A; Pan ML; Mukherjee J
Mol Imaging Biol; 2013 Apr; 15(2):222-9. PubMed ID: 22833323
[TBL] [Abstract][Full Text] [Related]
34. First-in-Humans Study of
Viitanen R; Moisio O; Lankinen P; Li XG; Koivumäki M; Suilamo S; Tolvanen T; Taimen K; Mali M; Kohonen I; Koskivirta I; Oikonen V; Virtanen H; Santalahti K; Autio A; Saraste A; Pirilä L; Nuutila P; Knuuti J; Jalkanen S; Roivainen A
J Nucl Med; 2021 Apr; 62(4):577-583. PubMed ID: 32817143
[TBL] [Abstract][Full Text] [Related]
35. Biodistribution, pharmacokinetics, dosimetry of [
Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Internal Dosimetry of 18 F-PSMA-1007 and 68 Ga-PSMA-11-HBED-CC.
Sharma P; Watts A; Singh H
Clin Nucl Med; 2022 Nov; 47(11):948-953. PubMed ID: 35961365
[TBL] [Abstract][Full Text] [Related]
37. Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside.
Li L; Lin X; Wang L; Ma X; Zeng Z; Liu F; Jia B; Zhu H; Wu A; Yang Z
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3735-3749. PubMed ID: 37382662
[TBL] [Abstract][Full Text] [Related]
38. Novel weight-based dose threshold for 18F-NaF PET-CT imaging using advanced PET-CT systems: a potential tool for reducing radiation burden.
Marafi F; Esmail A; Rasheed R; Alkandari F; Usmani S
Nucl Med Commun; 2017 Sep; 38(9):764-770. PubMed ID: 28723715
[TBL] [Abstract][Full Text] [Related]
39. Biodistribution and radiation dosimetry in healthy volunteers of a novel tumour-specific probe for PET/CT imaging: BAY 85-8050.
Smolarz K; Krause BJ; Graner FP; Wagner FM; Wester HJ; Sell T; Bacher-Stier C; Fels L; Dinkelborg L; Schwaiger M
Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1861-8. PubMed ID: 23877631
[TBL] [Abstract][Full Text] [Related]
40. Preclinical Evaluation and Pilot Clinical Study of Al
Liu T; Liu C; Xu X; Liu F; Guo X; Li N; Wang X; Yang J; Yang X; Zhu H; Yang Z
J Nucl Med; 2019 Sep; 60(9):1284-1292. PubMed ID: 30796170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]